Literature DB >> 16272481

Analysis of the effect of DNA purification on detection of human papillomavirus in oral rinse samples by PCR.

Gypsyamber D'Souza1, Elizabeth Sugar, William Ruby, Patti Gravitt, Maura Gillison.   

Abstract

Human papillomavirus (HPV) has recently been associated with oral cancers. To prepare for a study of the natural history of oral HPV infection, the effect of the DNA purification method on HPV genomic DNA detection in Scope mouthwash oral rinse samples and the reproducibility of HPV detection in rinse samples collected 7 days apart were investigated. The study was conducted with a population at high risk for oral HPV infection: human immunodeficiency virus-infected men with CD4-cell counts <200. Five DNA purification methods were compared among equal aliquots of oral rinse samples collected from a subset of individuals. The purification methods included (i) proteinase K digestion (PKD) and heat inactivation; (ii) PKD and ethanol precipitation (EP); (iii) PKD, phenol-chloroform extraction, and EP; (iv) use of the Puregene DNA purification kit; and (v) use of the QIAamp DNA Blood Midi kit. HPV was detected by PCR amplification with PGMY09 and PGMY11 L1 primer pools and by use of a Roche linear array. Puregene-purified samples had higher human DNA yields and purities, and Puregene purification detected the greatest number of HPV-positive subjects and total HPV infections in comparison to the numbers detected by all other methods. The total number of HPV infections and HPV prevalence estimates were also higher for Puregene-processed oral rinse samples when a fixed volume (10 mul) rather than a fixed cell number ( approximately 50,000 cells) was used for PCR amplification. A good concordance was observed for oral HPV infection status (agreement, 80%; kappa value, = 0.60) and type-specific infection (agreement, 98%; kappa value, 0.57) in matched oral rinse samples. The method of DNA purification significantly affects the detection of HPV genomic DNA from oral rinse samples and may result in exposure misclassification that could contribute to the inconsistent associations reported in the literature.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16272481      PMCID: PMC1287828          DOI: 10.1128/JCM.43.11.5526-5535.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  28 in total

1.  Improved amplification of genital human papillomaviruses.

Authors:  P E Gravitt; C L Peyton; T Q Alessi; C M Wheeler; F Coutlée; A Hildesheim; M H Schiffman; D R Scott; R J Apple
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

2.  Risk factors for oral human papillomavirus in adults infected and not infected with human immunodeficiency virus.

Authors:  F Coutlée; A M Trottier; G Ghattas; R Leduc; E Toma; G Sanche; I Rodrigues; B Turmel; G Allaire; P Ghadirian
Journal:  Sex Transm Dis       Date:  1997-01       Impact factor: 2.830

3.  Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men.

Authors:  J M Palefsky; E A Holly; M L Ralston; N Jay
Journal:  J Infect Dis       Date:  1998-02       Impact factor: 5.226

4.  Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method.

Authors:  P E Gravitt; C L Peyton; R J Apple; C M Wheeler
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

5.  Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescent girls: risk factors and differences, by phylogenetic type.

Authors:  Anna-Barbara Moscicki; Jonas H Ellenberg; Sepideh Farhat; Jiahong Xu
Journal:  J Infect Dis       Date:  2004-06-08       Impact factor: 5.226

6.  Vertical transmission of human papillomavirus from infected mothers to their newborn babies and persistence of the virus in childhood.

Authors:  M Puranen; M Yliskoski; S Saarikoski; K Syrjänen; S Syrjänen
Journal:  Am J Obstet Gynecol       Date:  1996-02       Impact factor: 8.661

7.  Human papillomaviruses in normal oral mucosa: a comparison of methods for sample collection.

Authors:  G Lawton; S Thomas; J Schonrock; F Monsour; I Frazer
Journal:  J Oral Pathol Med       Date:  1992-07       Impact factor: 4.253

8.  Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection.

Authors:  S M Schwartz; J R Daling; D R Doody; G C Wipf; J J Carter; M M Madeleine; E J Mao; E D Fitzgibbons; S Huang; A M Beckmann; J K McDougall; D A Galloway
Journal:  J Natl Cancer Inst       Date:  1998-11-04       Impact factor: 13.506

9.  Human papillomavirus and risk of oral cancer.

Authors:  E M Smith; H T Hoffman; K S Summersgill; H L Kirchner; L P Turek; T H Haugen
Journal:  Laryngoscope       Date:  1998-07       Impact factor: 3.325

10.  Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort.

Authors:  J Peto; C Gilham; J Deacon; C Taylor; C Evans; W Binns; M Haywood; N Elanko; D Coleman; R Yule; M Desai
Journal:  Br J Cancer       Date:  2004-08-31       Impact factor: 7.640

View more
  40 in total

1.  Automated high throughput DNA isolation for detection of human papillomavirus in oral rinse samples.

Authors:  Tatevik R Broutian; Xin He; Maura L Gillison
Journal:  J Clin Virol       Date:  2011-01-26       Impact factor: 3.168

2.  Associations between oral HPV16 infection and cytopathology: evaluation of an oropharyngeal "pap-test equivalent" in high-risk populations.

Authors:  Carole Fakhry; Barbara T Rosenthal; Douglas P Clark; Maura L Gillison
Journal:  Cancer Prev Res (Phila)       Date:  2011-08-11

3.  Human Papillomavirus Vaccination and Infection in Young Sexual Minority Men: The P18 Cohort Study.

Authors:  Perry N Halkitis; Pamela Valera; Caleb E LoSchiavo; Stephen E Goldstone; Maria Kanztanou; Anthony J Maiolatesi; Danielle C Ompad; Richard E Greene; Farzana Kapadia
Journal:  AIDS Patient Care STDS       Date:  2019-04       Impact factor: 5.078

4.  Human papillomavirus vaccine intentions among men participating in a human papillomavirus natural history study versus a comparison sample.

Authors:  Ellen M Daley; Stephanie L Marhefka; Eric R Buhi; Cheryl A Vamos; Natalie D Hernandez; Anna R Giuliano
Journal:  Sex Transm Dis       Date:  2010-10       Impact factor: 2.830

5.  A Randomized, Placebo-Controlled Trial of the Quadrivalent Human Papillomavirus Vaccine in Human Immunodeficiency Virus-Infected Adults Aged 27 Years or Older: AIDS Clinical Trials Group Protocol A5298.

Authors:  Timothy J Wilkin; Huichao Chen; Michelle S Cespedes; Jorge T Leon-Cruz; Catherine Godfrey; Elizabeth Y Chiao; Barbara Bastow; Jennifer Webster-Cyriaque; Qinghua Feng; Joan Dragavon; Robert W Coombs; Rachel M Presti; Alfred Saah; Ross D Cranston
Journal:  Clin Infect Dis       Date:  2018-10-15       Impact factor: 9.079

6.  A comparison of dacron versus Flocked nylon swabs for anal cytology specimen collection.

Authors:  Julia C Gage; Arpita Ghosh; Sylvia Borgonovo; Stephen Follansbee; Nicolas Wentzensen; Patti E Gravitt; Niels Grabe; Bernd Lahrmann; Philip E Castle
Journal:  Acta Cytol       Date:  2011-07-22       Impact factor: 2.319

7.  The Natural History of Oral Human Papillomavirus in Young Costa Rican Women.

Authors:  Daniel C Beachler; Krystle A Lang Kuhs; Linda Struijk; John Schussler; Rolando Herrero; Carolina Porras; Allan Hildesheim; Bernal Cortes; Joshua Sampson; Wim Quint; Paula Gonzalez; Aimée R Kreimer
Journal:  Sex Transm Dis       Date:  2017-07       Impact factor: 2.830

8.  Risk factors for acquisition and clearance of oral human papillomavirus infection among HIV-infected and HIV-uninfected adults.

Authors:  Daniel C Beachler; Elizabeth A Sugar; Joseph B Margolick; Kathleen M Weber; Howard D Strickler; Dorothy J Wiley; Ross D Cranston; Robert D Burk; Howard Minkoff; Susheel Reddy; Weihong Xiao; Yingshi Guo; Maura L Gillison; Gypsyamber D'Souza
Journal:  Am J Epidemiol       Date:  2014-12-04       Impact factor: 4.897

9.  Oral human papillomavirus infection before and after treatment for human papillomavirus 16-positive and human papillomavirus 16-negative head and neck squamous cell carcinoma.

Authors:  Yuri Agrawal; Wayne M Koch; Weihong Xiao; William H Westra; Anna L Trivett; David E Symer; Maura L Gillison
Journal:  Clin Cancer Res       Date:  2008-11-01       Impact factor: 12.531

10.  Quality of DNA extracted from mouthwashes.

Authors:  Tetyana Zayats; Terri L Young; David A Mackey; François Malecaze; Patrick Calvas; Jeremy A Guggenheim
Journal:  PLoS One       Date:  2009-07-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.